HPK1 억제제 및 그의 용도

HPK1 활성을 억제함으로써 치료가능한 질환 (예컨대, 암)을 치료하는데 유용한 하기 구조 화학식 (I-0) 또는 화학식 (II)에 의해 나타내어진 화합물, 또는 그의 제약상 허용되는 염 또는 입체이성질체가 본원에 제공된다. TIFFpct00429.tif2936TIFFpct00430.tif2448 The invention provides a compound represented by structural formula (I) or formula (II), or a pharmaceutically acceptable salt or a s...

Full description

Saved in:
Bibliographic Details
Main Authors ZHU XIAOTIAN, LIU RONGQIANG, ZHOU HUA, WEN KATE XIN, ZHONG WENGE, WU LEI, HUANG WEI, LIU HAO, FENG SONG
Format Patent
LanguageKorean
Published 08.04.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract HPK1 활성을 억제함으로써 치료가능한 질환 (예컨대, 암)을 치료하는데 유용한 하기 구조 화학식 (I-0) 또는 화학식 (II)에 의해 나타내어진 화합물, 또는 그의 제약상 허용되는 염 또는 입체이성질체가 본원에 제공된다. TIFFpct00429.tif2936TIFFpct00430.tif2448 The invention provides a compound represented by structural formula (I) or formula (II), or a pharmaceutically acceptable salt or a stereoisomer thereof useful for treating diseases (such as cancer) that are treatable by inhibiting HPKl activity.
AbstractList HPK1 활성을 억제함으로써 치료가능한 질환 (예컨대, 암)을 치료하는데 유용한 하기 구조 화학식 (I-0) 또는 화학식 (II)에 의해 나타내어진 화합물, 또는 그의 제약상 허용되는 염 또는 입체이성질체가 본원에 제공된다. TIFFpct00429.tif2936TIFFpct00430.tif2448 The invention provides a compound represented by structural formula (I) or formula (II), or a pharmaceutically acceptable salt or a stereoisomer thereof useful for treating diseases (such as cancer) that are treatable by inhibiting HPKl activity.
Author ZHONG WENGE
FENG SONG
HUANG WEI
LIU HAO
WEN KATE XIN
ZHU XIAOTIAN
WU LEI
LIU RONGQIANG
ZHOU HUA
Author_xml – fullname: ZHU XIAOTIAN
– fullname: LIU RONGQIANG
– fullname: ZHOU HUA
– fullname: WEN KATE XIN
– fullname: ZHONG WENGE
– fullname: WU LEI
– fullname: HUANG WEI
– fullname: LIU HAO
– fullname: FENG SONG
BookMark eNrjYmDJy89L5WRQ8AjwNlR4M23rmwVzgEjh9YZ-hVfbd7yZO0PhzayVr_tbeBhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJvHeQkYGRkYGBiYmJpamjMXGqAIseLo0
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20220044495A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20220044495A3
IEDL.DBID EVB
IngestDate Fri Oct 18 06:08:24 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20220044495A3
Notes Application Number: KR20227003145
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220408&DB=EPODOC&CC=KR&NR=20220044495A
ParticipantIDs epo_espacenet_KR20220044495A
PublicationCentury 2000
PublicationDate 20220408
PublicationDateYYYYMMDD 2022-04-08
PublicationDate_xml – month: 04
  year: 2022
  text: 20220408
  day: 08
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies QILU REGOR THERAPEUTICS INC
RelatedCompanies_xml – name: QILU REGOR THERAPEUTICS INC
Score 3.346818
Snippet HPK1 활성을 억제함으로써 치료가능한 질환 (예컨대, 암)을 치료하는데 유용한 하기 구조 화학식 (I-0) 또는 화학식 (II)에 의해 나타내어진 화합물, 또는 그의 제약상 허용되는 염 또는 입체이성질체가 본원에 제공된다....
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title HPK1 억제제 및 그의 용도
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220408&DB=EPODOC&locale=&CC=KR&NR=20220044495A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTJJsUhLMTfUNbNIM9Y1MU8z1E1MTknVNTMwTzIyS7I0SAHfouDrZ-YRauIVYRrBxJAD2wsDPie0HHw4IjBHJQPzewm4vC5ADGK5gNdWFusnZQKF8u3dQmxd1KC9YyMjYJq0UHNxsnUN8Hfxd1Zzdrb1DlLzC4LIgc5GszR1ZGZgBTakzUH5wTXMCbQvpQC5UnETZGALAJqXVyLEwJSdL8zA6Qy7e02YgcMXOuUNZEJzX7EIg4JHgLehwptpW98smANECq839Cu82r7jzdwZCm9mrXzd3yLKoOzmGuLsoQu0Kh7us3jvIGR3GYsxsAD7_KkSDAqJlmmGxmnmQJhsZmJpkWaZCgxGU9PEZNOUVCMzy2RJBhl8Jknhl5Zm4AJxwQtQLGQYWEqKSlNlgXVrSZIcOEgAqaGDLA
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTJJsUhLMTfUNbNIM9Y1MU8z1E1MTknVNTMwTzIyS7I0SAHfouDrZ-YRauIVYRrBxJAD2wsDPie0HHw4IjBHJQPzewm4vC5ADGK5gNdWFusnZQKF8u3dQmxd1KC9YyMjYJq0UHNxsnUN8Hfxd1Zzdrb1DlLzC4LIgc5GszR1ZGZgBTayzUH5wTXMCbQvpQC5UnETZGALAJqXVyLEwJSdL8zA6Qy7e02YgcMXOuUNZEJzX7EIg4JHgLehwptpW98smANECq839Cu82r7jzdwZCm9mrXzd3yLKoOzmGuLsoQu0Kh7us3jvIGR3GYsxsAD7_KkSDAqJlmmGxmnmQJhsZmJpkWaZCgxGU9PEZNOUVCMzy2RJBhl8Jknhl5Zn4PQI8fWJ9_H085Zm4AJJgRejWMgwsJQUlabKAuvZkiQ5cPAAAPsshh8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HPK1+%EC%96%B5%EC%A0%9C%EC%A0%9C+%EB%B0%8F+%EA%B7%B8%EC%9D%98+%EC%9A%A9%EB%8F%84&rft.inventor=ZHU+XIAOTIAN&rft.inventor=LIU+RONGQIANG&rft.inventor=ZHOU+HUA&rft.inventor=WEN+KATE+XIN&rft.inventor=ZHONG+WENGE&rft.inventor=WU+LEI&rft.inventor=HUANG+WEI&rft.inventor=LIU+HAO&rft.inventor=FENG+SONG&rft.date=2022-04-08&rft.externalDBID=A&rft.externalDocID=KR20220044495A